Clinical Trial Update: A Phase II, EvaluateBLEX 404 Combined With Gemcitabine Monotherapy With Pancreatic Cancer [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase II study evaluating EvaluateBLEX 404 in combination with gemcitabine for pancreatic cancer, which is currently NOT_…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• EvaluateBLEX 404
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Rgene Corporation | Conditions: Pancreatic Cancer | Phase 2 | Status: NOT_YET_RECRUITING